Johnson & Johnson buy Raymond James
Summary
This prediction ended on 25.07.24 with a price of €144.22. With a performance of -6.71%, the BUY prediction by Raymond_James finished with a loss. Raymond_James has a follow-up prediction for Johnson & Johnson where he still thinks Johnson & Johnson is a Buy. A total of €4.43 was paid as dividends for this prediction. Raymond_James has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Johnson & Johnson | 1.010% | 1.010% | -1.855% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
Comments by Raymond_James for this prediction
In the thread Johnson & Johnson diskutieren
In the thread Trading Johnson & Johnson
Current prediction by Raymond_James for Johnson & Johnson
Stopped prediction by Raymond_James for Johnson & Johnson
Johnson & Johnson
05.09.23
05.09.24
06.09.24